| MSD Merck Sharp & Dohme AG - Gardasil, Injektionssuspension | | 57735 | | 01 | | Gardasil | | Injektionssuspension | | J07BM01 | | Papillomavirus (Human Types 6, 11, 16, 18) | | 22.11.2006 | | |
| | Composition | | proteinum L1 papillomaviri humani typus 6 20 µg, proteinum L1 papillomaviri humani typus 11 40 µg, proteinum L1 papillomaviri humani typus 16 40 µg, proteinum L1 papillomaviri humani typus 18 20 µg, aluminium ut aluminii hydroxyphosphas sulfas amorphus, natrii chloridum, histidinum, polysorbatum 80, natrii boras, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml corresp. natrium 3.78 mg. | | Packungsbestandteile | | Injection suspension | | | | | | Active Agent | Dose |
|---|
| Proteinum L1 Papillomaviri Humani Typus 11 | 40µg / 0.5ml | | Proteinum L1 Papillomaviri Humani Typus 16 | 40µg / 0.5ml | | Proteinum L1 Papillomaviri Humani Typus 18 | 20µg / 0.5ml | | Proteinum L1 Papillomaviri Humani Typus 6 | 20µg / 0.5ml |
| | | | Inactive agents |
|---|
| Alumine | | Histidine | | Natrii Boras | | Sodium Chloride | | Polysorbatum 80 |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| No entries have been found. |
|
|
